Teva Pharmaceutical Industries Limited (TEV) — Financial Flexibility Index
Teva Pharmaceutical Industries Limited (TEV) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of €128.00 Million (operating CF €-40.00 Million minus capex €168.00 Million) represents 0% of total liabilities (€31.81 Billion). Check TEV strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Teva Pharmaceutical Industries Limited Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Teva Pharmaceutical Industries Limited across 11 annual periods. See Teva Pharmaceutical Industries Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year free cash flow to debt coverage for Teva Pharmaceutical Industries Limited. For the full company profile including market capitalisation, see Teva Pharmaceutical Industries Limited stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | €2.15 Billion | €1.65 Billion | €32.83 Billion | ▲ +26.1% |
| 2024 | 0.05x | €1.75 Billion | €1.25 Billion | €33.61 Billion | ▲ +7.6% |
| 2023 | 0.05x | €1.71 Billion | €1.16 Billion | €35.35 Billion | ▼ -20.3% |
| 2022 | 0.06x | €2.14 Billion | €1.59 Billion | €35.31 Billion | ▲ +62.1% |
| 2021 | 0.04x | €1.36 Billion | €798.00 Million | €36.42 Billion | ▼ -17.6% |
| 2020 | 0.05x | €1.79 Billion | €1.22 Billion | €39.58 Billion | ▲ +51.0% |
| 2019 | 0.03x | €1.27 Billion | €748.00 Million | €42.41 Billion | ▼ -56.5% |
| 2018 | 0.07x | €3.10 Billion | €2.45 Billion | €44.89 Billion | ▲ +15.5% |
| 2017 | 0.06x | €3.10 Billion | €2.23 Billion | €51.87 Billion | ▼ -27.8% |
| 2016 | 0.08x | €4.79 Billion | €3.89 Billion | €57.90 Billion | ▼ -68.1% |
| 2015 | 0.26x | €6.31 Billion | €5.54 Billion | €24.31 Billion | — |